Abstract
Although thyroid gland function is mainly under the control of pituitary TSH, other factors may also play a role in this process. Iodine is not used only by the thyroid to synthesize thyroid hormones but also directly influences a number of parameters such as thyroid proliferation and function. Thyroid autoregulation has been related to intraglandular content of an unknown putative iodocompound. The thyroid is capable of producing different iodolipids such as 6-iododeltalactone (ILδ) and 2-iodohexadecanal (2-IHDA). Data from different laboratories have shown that these iodolipids can inhibit several thyroid parameters suggesting that these compounds may be the intermediates in the thyroid autoregulation process.
Keywords: Iodine, iodocompounds, iodohexadecanal, iodolactone, iodolipids, thyroid, Thyroid NADPH oxidases, Metilmercaptoimidazol, Phosphatidyl inositol, Propylthiouracil, Urokinase-type plasminogen activator
Current Chemical Biology
Title: Thyroid: Iodine Beyond the Thyronines
Volume: 5 Issue: 3
Author(s): Guillermo J. Juvenal, Lisa Thomasz, Romina Oglio, Marina Perona, Mario A. Pisarev, Luiciano Rossich and Leonardo Salvarredi
Affiliation:
Keywords: Iodine, iodocompounds, iodohexadecanal, iodolactone, iodolipids, thyroid, Thyroid NADPH oxidases, Metilmercaptoimidazol, Phosphatidyl inositol, Propylthiouracil, Urokinase-type plasminogen activator
Abstract: Although thyroid gland function is mainly under the control of pituitary TSH, other factors may also play a role in this process. Iodine is not used only by the thyroid to synthesize thyroid hormones but also directly influences a number of parameters such as thyroid proliferation and function. Thyroid autoregulation has been related to intraglandular content of an unknown putative iodocompound. The thyroid is capable of producing different iodolipids such as 6-iododeltalactone (ILδ) and 2-iodohexadecanal (2-IHDA). Data from different laboratories have shown that these iodolipids can inhibit several thyroid parameters suggesting that these compounds may be the intermediates in the thyroid autoregulation process.
Export Options
About this article
Cite this article as:
J. Juvenal Guillermo, Thomasz Lisa, Oglio Romina, Perona Marina, A. Pisarev Mario, Rossich Luiciano and Salvarredi Leonardo, Thyroid: Iodine Beyond the Thyronines, Current Chemical Biology 2011; 5 (3) . https://dx.doi.org/10.2174/2212796811105030163
DOI https://dx.doi.org/10.2174/2212796811105030163 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sunitinib in the Treatment of Thyroid Cancer
Current Medicinal Chemistry Molecular Biomarkers of Anaplastic Thyroid Carcinoma
Current Molecular Medicine Changing the Endocrine Dependence of Breast Cancer: Data and Hypotheses
Current Medicinal Chemistry A Novel Bromomelatonin Derivative Suppresses Apoptosis with Regulating the Expression of Bcl-2 Family Genes
Letters in Drug Design & Discovery NCRNA Combined Therapy as Future Treatment Option for Cancer
Current Pharmaceutical Design Potential Adverse Effects Associated with Inhibition of p38α/β MAP Kinases
Current Topics in Medicinal Chemistry Discovery Approaches for Novel Dyslipidemia Drugs
Current Drug Discovery Technologies Serenoa Repens, Lycopene and Selenium: A Triple Therapeutic Approach to Manage Benign Prostatic Hyperplasia
Current Medicinal Chemistry Diagnostic Accuracy of Ultrasound for the Evaluation of Lateral Compartment Lymph Nodes in Papillary Thyroid Carcinoma
Current Medical Imaging NADPH Oxidases and Inflammatory Bowel Disease
Current Medicinal Chemistry Estrogen Receptor Polymorphisms: Significance to Human Physiology, Disease and Therapy
Recent Patents on DNA & Gene Sequences Nutrition and NSCLC; Should We Administer Food Supplements?
Current Pharmaceutical Design The Preclinical Bases of the Rational Combination of Paclitaxel and Antiangiogenic Drugs
Clinical Cancer Drugs Autoantibody Profiles as Biomarkers for Response to Therapy and Early Detection of Cancer
Current Cancer Therapy Reviews Predicted Contributions of Flavin-containing Monooxygenases to the N-oxygenation of Drug Candidates Based on their Estimated Base Dissociation Constants
Current Drug Metabolism Estrogen Regulation of MicroRNA Expression
Current Genomics VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets Targeting Stem Cells-Clinical Implications for Cancer Therapy
Current Stem Cell Research & Therapy An Overall Picture of Chemokine Receptors: Basic Research and Drug Development
Current Pharmaceutical Design Ovarian Toxicity: From Environmental Exposure to Chemotherapy
Current Pharmaceutical Design